Sign in

CIK 0001425205

  • Accelerated filer

IOVANCE BIOTHERAPEUTICS, INC.

Sign in to watch
Ticker
IOVA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
753254381
Phone
+1 650-260-7120
Business address
825 INDUSTRIAL ROAD, 4TH FLOOR, SAN CARLOS, CA, 94070
Former names
Lion Biotechnologies, Inc., Genesis Biopharma, Inc, FREIGHT MANAGEMENT CORP
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 99 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-01-03 Bellemin Jean-Marc Chief Financial Officer Option exercise +18,850 28,354
2023-01-03 Bellemin Jean-Marc Chief Financial Officer Shares withheld for taxes −10,553 $6.11 $64K 17,801
2023-01-03 Bellemin Jean-Marc Chief Financial Officer Option exercise · Restricted Stock Units −18,850 0
2022-12-21 MCPEAK MERRILL A Director Purchase +10,000 $6.15 $62K 70,150
2022-12-02 Rothbaum Wayne P. Director Purchase +10,000,000 $6.50 $65.0M 18,067,333
2022-11-29 MCPEAK MERRILL A Director Purchase +10,000 $6.31 $63K 238,633
2022-11-28 Vogt Frederick G Interim CEO & General Counsel Purchase +1,000 $5.98 $6K 2,000
2022-11-28 MCPEAK MERRILL A Director Purchase +10,000 $6.18 $62K 228,633
2022-11-23 Dukes Iain D. Director Purchase +10,000 $6.10 $61K 22,000
2022-08-23 MCPEAK MERRILL A Director Option exercise +40,000 $5.65 $226K 60,150
2022-08-23 MCPEAK MERRILL A Director Option exercise · Stock Option (right to buy) +40,000 0
2022-06-14 GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer Option exercise +19,690 19,690
2022-06-14 GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer Shares withheld for taxes −6,809 $7.73 $53K 12,881
2022-06-14 GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer Grant or award · Restricted Stock Units +19,690 19,690
2022-06-14 Bellemin Jean-Marc Chief Financial Officer Option exercise +18,850 18,850
2022-06-14 Bellemin Jean-Marc Chief Financial Officer Shares withheld for taxes −9,346 $7.73 $72K 9,504
2022-06-14 Bellemin Jean-Marc Chief Financial Officer Grant or award · Restricted Stock Units +18,850 18,850
2022-06-14 BILINSKY IGOR Chief Operating Officer Option exercise +18,850 18,850
2022-06-14 BILINSKY IGOR Chief Operating Officer Shares withheld for taxes −9,346 $7.73 $72K 9,504
2022-06-14 BILINSKY IGOR Chief Operating Officer Grant or award · Restricted Stock Units +18,850 18,850

Page 20 of 23 · 446 trades